seed
Stage
1
Investors
About
PhosPrint develops laser bioprinting systems for precise delivery of cells and bio-inks onto targeted tissues in vivo, focusing on regenerative medicine applications such as urinary bladder repair, with preclinical studies completed and progressing toward clinical trials.
Explore PhosPrint's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.